Literature DB >> 17495279

The effects of food on the pharmacokinetics of a formulated ACP-103 tablet in healthy volunteers.

Kimberly E Vanover1, Doris Robbins-Weilert, Darren G Wilbraham, Timothy G K Mant, Daniel P van Kammen, Robert E Davis, David M Weiner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17495279     DOI： 10.1177/0091270007299361

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  5 in total

Review 1.  Pimavanserin: A Novel Drug Approved to Treat Parkinson's Disease Psychosis.

Authors:  Amanda K Kitten; Sarah A Hallowell; Stephen R Saklad; Kirk E Evoy
Journal:  Innov Clin Neurosci       Date:  2018-02-01

Review 2.  Evidence for the use of pimavanserin in the treatment of Parkinson's disease psychosis.

Authors:  Harini Sarva; Claire Henchcliffe
Journal:  Ther Adv Neurol Disord       Date:  2016-10-03       Impact factor: 6.570

Review 3.  New Antipsychotic Medications in the Last Decade.

Authors:  Mehak Pahwa; Ahmad Sleem; Omar H Elsayed; Megan Elizabeth Good; Rif S El-Mallakh
Journal:  Curr Psychiatry Rep       Date:  2021-11-29       Impact factor: 5.285

Review 4.  Pimavanserin: First Global Approval.

Authors:  Anthony Markham
Journal:  Drugs       Date:  2016-07       Impact factor: 9.546

Review 5.  On the discovery and development of pimavanserin: a novel drug candidate for Parkinson's psychosis.

Authors:  Uli Hacksell; Ethan S Burstein; Krista McFarland; Roger G Mills; Hilde Williams
Journal:  Neurochem Res       Date:  2014-03-30       Impact factor: 3.996
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.